Bausch Health Files 8-K on Financials
Ticker: BHC · Form: 8-K · Filed: Oct 29, 2025 · CIK: 885590
Sentiment: neutral
Topics: financial-reporting, 8-K
TL;DR
Bausch Health dropped an 8-K on Oct 29th covering financials. Check it.
AI Summary
Bausch Health Companies Inc. filed an 8-K on October 29, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits, with the company's principal executive offices located in Laval, Quebec, Canada.
Why It Matters
This 8-K filing provides crucial updates on Bausch Health's financial performance and operational status, which can influence investor decisions and market perception.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for financial reporting and does not indicate any immediate or unusual risks.
Key Players & Entities
- Bausch Health Companies Inc. (company) — Registrant
- October 29, 2025 (date) — Filing Date
- Laval, Quebec, Canada (location) — Principal Executive Offices
- Valeant Pharmaceuticals International, Inc. (company) — Former Company Name
- BIOVAIL Corp (company) — Former Company Name
FAQ
What specific financial information is being reported in this 8-K?
The 8-K filing indicates it covers 'Results of Operations and Financial Condition' and includes 'Financial Statements and Exhibits'.
When was this 8-K report filed?
The report was filed on October 29, 2025.
Where are Bausch Health Companies Inc.'s principal executive offices located?
The principal executive offices are located at 2150 St. Elzéar Blvd. West, Laval, Québec, Canada H7L 4A8.
What is Bausch Health Companies Inc.'s IRS Employer Identification No.?
The IRS Employer Identification No. is 98-0448205.
Has Bausch Health Companies Inc. operated under any former names?
Yes, the company was formerly known as Valeant Pharmaceuticals International, Inc. and BIOVAIL Corp.
Filing Stats: 615 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2025-10-29 16:09:41
Filing Documents
- bhc-20251029.htm (8-K) — 29KB
- ex991-q3x2025.htm (EX-99.1) — 798KB
- image2a.jpg (GRAPHIC) — 8KB
- 0000885590-25-000048.txt ( ) — 1005KB
- bhc-20251029.xsd (EX-101.SCH) — 2KB
- bhc-20251029_lab.xml (EX-101.LAB) — 22KB
- bhc-20251029_pre.xml (EX-101.PRE) — 13KB
- bhc-20251029_htm.xml (XML) — 3KB
02. Results of Operations and Financial Condition
Item 2.02. Results of Operations and Financial Condition. On October 29, 2025, Bausch Health Companies Inc. (the "Company") issued a press release announcing results of operations for the quarter ended September 30, 2025 and certain other financial information as of and for the quarter ended September 30, 2025. A copy of the press release is attached as Exhibit 99.1 to this report and is incorporated herein by this reference. This Current Report on Form 8-K and the press release attached hereto as Exhibit 99.1 do not constitute an offer to sell or the solicitation of an offer to buy any securities. The information in this Item 2.02, including Exhibit 99.1, is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section. The information in this Item 2.02 and Exhibit 99.1 shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended (the " Securities Act").
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1* Press Release of Bausch Health Companies Inc., respecting financial results for the third quarter of 2025 dated October 29, 2025 101.SCH* XBRL Taxonomy Extension Schema Document 101.LAB* XBRL Taxonomy Extension Label Linkbase Document 101.PRE* XBRL Taxonomy Extension Presentation Linkbase Document 104* Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) ____________________________________ * Filed herewith.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 29, 2025 BAUSCH HEALTH COMPANIES INC. By: /s/ JEAN-JACQUES CHARHON Jean-Jacques Charhon Executive Vice President, Chief Financial Officer (Principal Financial Officer)